Trade Mark Journal No.2025/051 19 December 2025

UK00004308487 10 December 2025 (1,5,42)

HELUS PHARMA

International priority date claimed: 5 December 2025 (United States of America) (99531372)

Class 1: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders; pharmaceutical active ingredients for clinical trials.
Class 5: Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; pharmaceutical preparations for the treatment of depression and anxiety; pharmaceutical preparations for human use.
Class 42: Pharmaceutical drug development services; pharmaceutical research and development services; consultancy relating to pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for pharmaceutical products; scientific research for medical and healthcare purposes; product research and development in the field of major depressive disorders and other mental health disorders; providing medical and scientific research information in the field of clinical trials.

Cybin Corp.

Representative: Stobbs